• 1. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 4. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 5. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381

Professional Introduction to 1-Bromo-2-methylpropane-3,3,3-d3 (CAS No. 344299-42-9)

1-Bromo-2-methylpropane-3,3,3-d3, identified by the chemical abstracts service number 344299-42-9, is a specialized isotope-labeled compound that has garnered significant attention in the field of organic synthesis and pharmaceutical research. This deuterated derivative of 1-bromo-2-methylpropane is particularly valued for its utility in studying metabolic pathways and drug metabolism through deuterium labeling techniques. The introduction of deuterium atoms at the 3-position provides a unique tool for researchers to investigate the kinetics of reactions and the fate of molecules within biological systems.

The compound’s structure, featuring a bromine substituent on a tertiary carbon and deuterium atoms at the third position, makes it an ideal candidate for mechanistic studies in organic chemistry. The bromine atom serves as a versatile handle for further functionalization, allowing chemists to construct more complex molecules via cross-coupling reactions, nucleophilic substitutions, or other transformations. Meanwhile, the deuterium-labeled version enables precise tracking of reaction pathways, which is crucial for understanding how pharmaceuticals are metabolized in vivo.

In recent years, the demand for labeled compounds like 1-Bromo-2-methylpropane-3,3,3-d3 has surged due to advancements in mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy techniques. These methods allow researchers to detect and quantify trace amounts of labeled substances, making them indispensable in drug discovery and development. The use of deuterium-labeled compounds helps in minimizing interference from endogenous compounds during analytical studies, thereby enhancing the accuracy and reliability of experimental results.

One of the most compelling applications of 1-Bromo-2-methylpropane-3,3,3-d3 is in the field of metabolic flux analysis. By incorporating this labeled compound into biological systems, researchers can trace the movement of atoms through metabolic pathways with high precision. This approach has been particularly useful in studying how drugs are processed by enzymes such as cytochrome P450 monooxygenases. The ability to monitor deuterium exchange patterns provides insights into the catalytic mechanisms and helps in optimizing drug candidates for better bioavailability and reduced side effects.

The pharmaceutical industry has also leveraged 1-Bromo-2-methylpropane-3,3,3-d3 for the synthesis of labeled analogs of active pharmaceutical ingredients (APIs). Deuterium labeling can enhance the metabolic stability of drugs, making them less susceptible to degradation by enzymes or other metabolic processes. This can lead to improved pharmacokinetic profiles, including longer half-lives and lower dosing requirements. Furthermore, labeled drugs are often used as probes in clinical studies to assess their distribution and excretion patterns more accurately.

Another emerging area where 1-Bromo-2-methylpropane-3,3,3-d3 finds utility is in polymer chemistry. Deuterated monomers derived from this compound can be incorporated into polymers to study their degradation or reaction mechanisms under various conditions. The bromine atom allows for further modifications via polymerization techniques such as radical or cationic polymerization, enabling the creation of tailored materials with specific properties.

The synthesis of 1-Bromo-2-methylpropane-3,3,3-d3 involves careful control over reaction conditions to ensure high isotopic purity and yield. Traditional methods typically involve bromination followed by deuteration using deuterium gas or deuterated reagents under inert atmospheres. Advances in catalytic deuteration have made it possible to achieve higher efficiencies and selectivities, reducing costs and improving scalability for industrial applications.

As research continues to evolve, the applications of 1-Bromo-2-methylpropane-3,3,3-d3 are expected to expand further. Innovations in synthetic methodologies and analytical techniques will continue to drive demand for this compound across various scientific disciplines. Its role in understanding complex biological processes and developing next-generation pharmaceuticals underscores its importance as a research tool.

In conclusion,1-Bromo-2-methylpropane-3,3,3-d3 (CAS No. 344299-42-9) represents a cornerstone compound in modern chemical research. Its unique structural features and isotopic labeling make it an invaluable asset for studying reaction mechanisms、metabolic pathways、and material science applications. As scientists continue to uncover new possibilities，the utility of this compound is bound to grow，further solidifying its place as a key player in advancing scientific knowledge and innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)